During the past decade, HSCT department conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "HSCT department" are "GATA2 Deficiency" (1 trials), "Nijmegen Breakage Syndrome" (1 trials) and "Severe Congenital Neutropenia" (1 trials). Many other conditions were trialed in "HSCT department" in a lesser frequency.

Most popular intervention types in "HSCT department" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Treosulfan" (1 trials) and "conditioning with TLI" (1 trials). Other intervention names were less common.

The vast majority of trials in "HSCT department" are 2 trials for "All" genders.

Currently, there are NaN active trials in "HSCT department". 1 are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in HSCT department, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in HSCT department, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".